Piramal Pharma gained 2.09% to Rs 144.30 after the US drug regulator issued an Establishment Inspection Report (EIR) for the Riverview, USA facility stating the inspection to be closed.
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
